With Pfizer As Cornerstone Investor, Will Shanghai Pharmaceutical Be Largest Pharma IPO Ever?
This article was originally published in The Pink Sheet Daily
Executive Summary
The company has secured four cornerstone investors to purchase shares together worth $550 million, with total net proceeds from the global offering possibly reaching as high $2.46 billion.